Citations
299 citation(s) found for "Sargent, Daniel J".
Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).
Wilcox, Ryan Eldredge, Foster, Nathan R. , Meyers, Jeffrey P., Goldberg, Richard M. , Nair, Suresh , Shields, Anthony F. , Chan, Emily , Kahlenberg, Morton S., Shi, Qian , Sinicrope, Frank A. , Sargent, Daniel J. , Gill, Sharlene , Alberts, Steven R.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3590-3590
Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) receiving adjuvant chemotherapy: Results from NCCTG N0147 (Alliance).
Foster, Nathan R. , Grothey, Axel, Chan, Emily , Shields, Anthony F. , Goldberg, Richard M. , Kahlenberg, Morton S., Singh, Preet Paul , Shi, Qian , Nair, Suresh, Gill, Sharlene , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3531-3531
Alcohol consumption and prognosis in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance).
Phipps, Amanda I. , Nelson, Garth D. , Chan, Emily , Goldberg, Richard M. , Kahlenberg, Morton S., Nair, Suresh , Shields, Anthony F. , Shi, Qian , Limburg, Paul J. , Sargent, Daniel J. , Sinicrope, Frank A. , Gill, Sharlene , Newcomb, Polly A. , Alberts, Steven R.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1508-1508
Calculators for overall survival (OS) and progression-free survival (PFS) in metastatic colorectal cancer (mCRC): Construction from 19,678 ARCAD patients.
Sjoquist, Katrin Marie , Bokemeyer, Carsten , Renfro, Lindsay A. , Simes, John, Clarke, Stephen , Punt, Cornelis J. A. , Douillard, Jean‐Yves , Hecht, J. Randolph , Heinemann, Volker , Sougklakos, Ioannis, Porschen, Rainer, Meyers, Jeffrey P., Gramont, Aimery de , Group, Fondation Aide et Récherce en Cancerologie Digestive (ARCAD), Tebbutt, Niall C. , Adams, Richard , Cutsem, Eric Van , Díaz‐Rubio, Eduardo , Gonsalves, Wilson I. , Sargent, Daniel J. , Zalcberg, John , Group, Fondation Aide et Récherce en Cancerologie Digestive (ARCAD)
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3555-3555
Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 tria
Thibodeau, Stephen N. , Mini, Enrico , Goldberg, Richard M. , Folprecht, Gunnar , Laethem, Jean‐Luc Van , Laurent‐Puig, Pierre , Laurent-Puig, Pierre , Taı̈eb, Julien , Malicot, Karine Le , Penault-Llorca, Frederique Madeleine , Bouché, Olivier , Shi, Qian , Tabernero, Josep , Sargent, Daniel J. , Alberts, Steven R. , Sinicrope, Frank A.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3507-3507
Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients (pts) treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials.
Smyrk, Thomas C. , Julié, Catherine , Zawadi, Ayman, Mini, Enrico , Goldberg, Richard M. , Folprecht, Gunnar , Laethem, Jean‐Luc Van , Laurent‐Puig, Pierre , Laurent-Puig, Pierre , Zaanan, Aziz , Shi, Qian , Taı̈eb, Julien , Alberts, Steven R. , Tabernero, Josep , Malicot, Karine Le , Sargent, Daniel J. , Sinicrope, Frank A.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3506-3506
Survival following stage II/III colon cancer (CC): Accent-based comparison versus matched general population (MGP).
Renfro, Lindsay A. , Haller, Daniel G. , Loprinzi, Charles L. , Twelves, Chris, Group, Adjuvant Colon Cancer Endpoints (ACCENT), Grothey, Axel , Kerr, David , André, Thierry , Cutsem, Eric Van , Saltz, Leonard B. , Labianca, Roberto , Alberts, Steven R. , Schmoll, Hans‐Joachim , Yothers, Greg , Sargent, Daniel J. , Group, Adjuvant Colon Cancer Endpoints (ACCENT)
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3601-3601
Early predictors of improved long-term outcomes in first-line antiangiogenics plus chemotherapy (anti-ANG/CT) in metastatic colorectal cancer (mCRC): Analysis of individual patient (pt) data from the ARCAD database.
Saad, Everardo D. , Coart, Elisabeth , Sommeijer, Dirkje W. , Meyers, Jeffrey P., Hecht, J. Randolph , Hurwitz, Herbert I. , Tol, Jolien , Fuchs, Charles S. , Souglakos, John , Kabbinavar, Fairooz F. , Gramont, Aimery de , Group, for the ARCAD, Shi, Qian , Zalcberg, John , Burzykowski, Tomasz , Hoff, Paulo M. , Tebbutt, Niall C. , Díaz‐Rubio, Eduardo , Falcone, Alfredo , Sargent, Daniel J. , Buyse, Marc , Group, for the ARCAD
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3578-3578
Overall survival result and outcomes by KRAS, BRAF, andDNA mismatch repair in relation to primary tumor site in colon cancers from a randomized trial of adjuvant chemotherapy: NCCTG (Alliance) N0147.
Yoon, Harry H. , Mahoney, Michelle R., Nelson, Garth D. , Thibodeau, Stephen N. , Goldberg, Richard M. , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3525-3525
Combining survival and toxicity effect sizes from clinical trials into an interpretable, quality-adjusted survival effect size estimate of treatment efficacy.
Sloan, Jeff A. , Major, Brittny , Novotny, Paul J. , Marks, Randolph S., Grothey, Axel , Sargent, Daniel J. , Dueck, Amylou C.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 6630-6630